Cargando…
Burden of Acute Viral Hepatitis — China, 1990−2019
What is already known about this topic? The World Health Organization’s (WHO) Global Health Estimates (GHE) reported that acute hepatitis caused 9,213 deaths and 307,720 person years of disability-adjusted life years (DALYs) in 2016, and acute hepatitis B accounted for 85.81% of all DALYs among acut...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428429/ https://www.ncbi.nlm.nih.gov/pubmed/34594713 http://dx.doi.org/10.46234/ccdcw2020.156 |
_version_ | 1783750375495434240 |
---|---|
author | Yu, Shicheng Wang, Qiqi Wang, Shujun Zhang, Jiaojiao Hu, Yuehua Li, Junqi Long, Xiaojuan Xiang, Xianglong Zhou, Maigeng Tan, Feng |
author_facet | Yu, Shicheng Wang, Qiqi Wang, Shujun Zhang, Jiaojiao Hu, Yuehua Li, Junqi Long, Xiaojuan Xiang, Xianglong Zhou, Maigeng Tan, Feng |
author_sort | Yu, Shicheng |
collection | PubMed |
description | What is already known about this topic? The World Health Organization’s (WHO) Global Health Estimates (GHE) reported that acute hepatitis caused 9,213 deaths and 307,720 person years of disability-adjusted life years (DALYs) in 2016, and acute hepatitis B accounted for 85.81% of all DALYs among acute hepatitis types A, B, C, and E in China. What is added by this report? In China, the percent changes in years lived with disability (YLDs) due to acute hepatitis A, B, and E in groups aged 50–69 years and 70 years or more and in all age groups for acute hepatitis C were increased from 2000 to 2019. What are the implications for public health practices? Effective vaccines, interventions, and treatments are key approaches to achieve the WHO’s goal of reducing new hepatitis infections by 90% and deaths by 65% between 2016 and 2030. |
format | Online Article Text |
id | pubmed-8428429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-84284292021-09-29 Burden of Acute Viral Hepatitis — China, 1990−2019 Yu, Shicheng Wang, Qiqi Wang, Shujun Zhang, Jiaojiao Hu, Yuehua Li, Junqi Long, Xiaojuan Xiang, Xianglong Zhou, Maigeng Tan, Feng China CDC Wkly Preplanned Studies What is already known about this topic? The World Health Organization’s (WHO) Global Health Estimates (GHE) reported that acute hepatitis caused 9,213 deaths and 307,720 person years of disability-adjusted life years (DALYs) in 2016, and acute hepatitis B accounted for 85.81% of all DALYs among acute hepatitis types A, B, C, and E in China. What is added by this report? In China, the percent changes in years lived with disability (YLDs) due to acute hepatitis A, B, and E in groups aged 50–69 years and 70 years or more and in all age groups for acute hepatitis C were increased from 2000 to 2019. What are the implications for public health practices? Effective vaccines, interventions, and treatments are key approaches to achieve the WHO’s goal of reducing new hepatitis infections by 90% and deaths by 65% between 2016 and 2030. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020-07-31 /pmc/articles/PMC8428429/ /pubmed/34594713 http://dx.doi.org/10.46234/ccdcw2020.156 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) |
spellingShingle | Preplanned Studies Yu, Shicheng Wang, Qiqi Wang, Shujun Zhang, Jiaojiao Hu, Yuehua Li, Junqi Long, Xiaojuan Xiang, Xianglong Zhou, Maigeng Tan, Feng Burden of Acute Viral Hepatitis — China, 1990−2019 |
title | Burden of Acute Viral Hepatitis — China, 1990−2019 |
title_full | Burden of Acute Viral Hepatitis — China, 1990−2019 |
title_fullStr | Burden of Acute Viral Hepatitis — China, 1990−2019 |
title_full_unstemmed | Burden of Acute Viral Hepatitis — China, 1990−2019 |
title_short | Burden of Acute Viral Hepatitis — China, 1990−2019 |
title_sort | burden of acute viral hepatitis — china, 1990−2019 |
topic | Preplanned Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428429/ https://www.ncbi.nlm.nih.gov/pubmed/34594713 http://dx.doi.org/10.46234/ccdcw2020.156 |
work_keys_str_mv | AT yushicheng burdenofacuteviralhepatitischina19902019 AT wangqiqi burdenofacuteviralhepatitischina19902019 AT wangshujun burdenofacuteviralhepatitischina19902019 AT zhangjiaojiao burdenofacuteviralhepatitischina19902019 AT huyuehua burdenofacuteviralhepatitischina19902019 AT lijunqi burdenofacuteviralhepatitischina19902019 AT longxiaojuan burdenofacuteviralhepatitischina19902019 AT xiangxianglong burdenofacuteviralhepatitischina19902019 AT zhoumaigeng burdenofacuteviralhepatitischina19902019 AT tanfeng burdenofacuteviralhepatitischina19902019 |